Viking Thera (VKTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 165,810 | 100,376 | 33,880 | 37,940 | 26,676 |
| Marketable Securities | 539,929 | 614,194 | 773,844 | 813,918 | 875,936 |
| TOTAL | $715,598 | $738,703 | $827,017 | $866,023 | $907,216 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 131 | 712 | 834 | 970 | 1,105 |
| TOTAL | $131 | $712 | $834 | $970 | $1,105 |
| Total Assets | $715,729 | $739,415 | $827,851 | $866,993 | $908,321 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 53,251 | 4,413 | 5,494 | 7,702 | 9,813 |
| TOTAL | $76,667 | $26,067 | $31,980 | $19,573 | $27,413 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 318 | 410 | 502 | 630 |
| TOTAL | $N/A | $318 | $410 | $502 | $630 |
| Total Liabilities | $76,667 | $26,385 | $32,390 | $20,075 | $28,043 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 115,554 | 113,036 | 112,445 | 112,310 | 112,248 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -847,546 | -689,884 | -599,097 | -533,536 | -487,907 |
| Other shareholders' equity | 378 | 374 | -166 | -216 | -788 |
| TOTAL | $639,062 | $713,030 | $795,461 | $846,918 | $880,278 |
| Total Liabilities And Equity | $715,729 | $739,415 | $827,851 | $866,993 | $908,321 |